Market Snapshot
S&P Futures
4,285.75
Dow Futures
33,941
Nasdaq Futures
13,555.25
Profound Medical Corp. (PROF) stock rallied over 1.00% intraday to trade at $7.1711 a share on NASDAQ. The stock opened with a loss of -1.50% at $7.145 and touched an intraday high of $7.145, falling -0.81% against the last close of $7.23. The stock went to a low of $7.01 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-17 | $7.145 | $7.145 | $7.01 | $7.08 | 7,594 |
2022-08-16 | $7.28 | $7.28 | $7.06 | $7.23 | 16,600 |
2022-08-15 | $7.39 | $7.39 | $7.13 | $7.21 | 5,800 |
2022-08-12 | $7.38 | $7.49 | $7.22 | $7.39 | 9,300 |
2022-08-11 | $7.36 | $7.431 | $7.2 | $7.33 | 5,400 |
2022-08-10 | $7.269 | $7.303 | $7.15 | $7.27 | 3,600 |
2022-08-09 | $7.47 | $7.49 | $7.05 | $7.07 | 17,500 |
2022-08-08 | $7.54 | $7.805 | $7.38 | $7.42 | 11,100 |
2022-08-05 | $8.76 | $8.955 | $7.07 | $7.38 | 124,800 |
2022-08-04 | $9.387 | $9.4 | $8.86 | $9.3 | 23,800 |
Employees-
Beta-
Sales or Revenue7.53 Million
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryHealth Care Equipment
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
Profound Medical Corp. (NASDAQ: PROF) stock price is $7.1711 as of the last check on Wednesday, August 17. During the trading session, PROF stock reached the peak price of $7.145 while $7.01 was the lowest point it dropped to.
The NASDAQ listed PROF is part of Health Care Equipment industry that operates in the broader Health Care sector. Profound Medical Corp. , together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland.
Mr. Rashed Dewan
Chief Accounting Officer, VP of Fin., Manufacturing & HR Operations
Mr. Aaron Davidson M.B.A., MBA
Sr. VP of Corp. Devel.
Mr. Jacques F. Cornet
VP of Marketing & Bus. Devel.
Dr. Arun Swarup Menawat MBA, Ph.D.
Chairman & CEO
PROF stock traded closed the last session at $7.08, which is $0.07110000000000039 or 1.001408450704231% lower than its previous close of $7.23. PROF's current trading price is 16.26% lower than its 52-week high of $16.34 where as its distance from 52-week low of 6.09% is -56.67%.
Number of PROF employees currently stands at -. PROF operates from 2400 Skymark Avenue, Unit 6, Mississauga, ON L4W 5K5, Canada.
Official Webiste of $PROF is: https://www.profoundmedical.com
PROF could be contacted at PROF operates from 2400 Skymark Avenue, Unit 6, Mississauga, ON L4W 5K5, Canada, or at phone # and can also be accessed through its website.
PROF stock volume for the day was 469 shares while in the previous session number of PROF shares traded was 7,594 . The average number of PROF shares traded daily for last 3 months was 24.19 Thousands.
The percentage change in PROF stock occurred in the recent session was 1.001408450704231% while the dollar amount for the price change in PROF stock was $0.07110000000000039.
In the recent session, the day high for PROF stock was $7.145 while the low for PROF stock touched on the day was $7.01.
The market value of PROF currently stands at 147.05 Million with its latest stock price at $7.1711 and 20.77 Million of its shares outstanding.